News & Updates
Filter by Specialty:
Trazodone, CBT for insomnia only as good as placebo in haemodialysis patients
Cognitive behavioural therapy for insomnia (CBT-I) or trazodone appear to be no better than placebo in the treatment of insomnia among patients undergoing long-term haemodialysis, reveals a study. In addition, trazodone use is associated with a higher incidence of serious adverse events (SAEs).
Trazodone, CBT for insomnia only as good as placebo in haemodialysis patients
23 Jan 2024
Xanomeline–trospium beneficial in treatment of schizophrenia
Treatment with the combination of xanomeline plus trospium leads to favourable reduction in positive and negative symptoms in patients with schizophrenia, while being well tolerated, according to data from the phase III EMERGENT-2 trial.
Xanomeline–trospium beneficial in treatment of schizophrenia
16 Jan 2024
NIH study: Semaglutide associated with lower risk of suicidal ideation
Semaglutide is associated with a 49─73 percent lower risk of suicidal ideation vs other agents for treatment of obesity and type 2 diabetes mellitus (T2DM), a National Institutes of Health (NIH)─funded study has shown.
